Polypodium Leucotomos: The Fern Extract Behind Heliocare and What It Actually Does for Your Skin

Walk into a dermatology office in Spain or Latin America and you’ll see it on the counter long before you see it in the United States: Heliocare, a small box of capsules taken once a day with the explicit promise of helping your skin handle the sun. Open the bottle and the active is the same one used in dozens of similar products worldwide — Polypodium leucotomos extract, a compound derived from a tropical fern that has spent thirty years quietly accumulating a respectable evidence base.

Most people who hear about it for the first time react the same way: an oral sunscreen sounds like wishful thinking. The actual story is more interesting, and more limited, than the marketing suggests.

What Polypodium Leucotomos Actually Is

Polypodium leucotomos is a fern native to Central and South America, traditionally used in Honduran and Mayan medicine for inflammatory skin conditions. The standardized aqueous extract — sold as PLE, sometimes branded as Fernblock — concentrates the polyphenols and other antioxidant compounds responsible for its biological activity.

The major active components are phenolic acids: ferulic acid, caffeic acid, p-coumaric acid, vanillic acid, and chlorogenic acid. Several of these (ferulic and caffeic) are familiar to anyone who has read the back of a topical antioxidant serum. PLE concentrates them in a form designed to be absorbed orally and reach the skin via the bloodstream.

How It Works (The Mechanism)

UV radiation does two main types of damage to skin: direct DNA damage and oxidative damage from reactive oxygen species (ROS). Sunscreen blocks the UV photons before they hit the skin. Polypodium leucotomos works downstream — once UV gets through, PLE helps neutralize the cascade of damage that follows.

Specifically, the extract has been shown to:

• Neutralize reactive oxygen species generated by UV exposure (superoxide anions, hydroxyl radicals, lipid peroxides) [1]
• Reduce UV-induced DNA damage by accelerating removal of cyclobutane pyrimidine dimers — the same DNA lesions that drive both photoaging and skin cancer [2]
• Inhibit matrix metalloproteinases (MMPs) activated by UV, the enzymes that fragment dermal collagen and accelerate wrinkling
• Protect Langerhans cells — the immune cells in the epidermis that UV depletes
• Decrease mast cell infiltration in UV-irradiated skin, blunting the inflammatory response

The net effect is a measurable increase in the skin’s tolerance for UV before damage shows up clinically.

The Clinical Trial Evidence

The strength of PLE as a supplement rests on several randomized controlled trials with consistent results.

Increased Minimal Erythema Dose (MED)

A randomized, double-blind, placebo-controlled trial of 240 mg PLE twice daily in healthy adults found that subjects on PLE were 22 times more likely to experience an increased minimal erythema dose — the UV exposure threshold at which the skin starts to redden — and 15 times more likely to show reduced UV-induced erythema intensity compared to placebo [3]. Subjects on PLE were also six times more likely to avoid sunburn than those on placebo.

A 2025 trial of an eight-week supplementation containing red orange and Polypodium leucotomos extracts reported a 23.8% increase in MED and a 46.2% reduction in erythema intensity in the treatment group [4]. In other words, treated skin tolerated more UV before reddening, and reddened less when it did.

Most people who hear about it for the first time react the same way: an oral sunscreen sounds like wishful thinking.

Histological Protection

Beyond what shows up on the surface, biopsies of PLE-treated skin show fewer sunburn cells, fewer cyclobutane pyrimidine dimers, less proliferation of UV-damaged epidermal cells, and reduced dermal mast cell infiltration [5]. The protection is real at the cellular level, not just on a colorimeter.

Melasma — The Most Studied Pigmentary Use

A randomized, double-blind, placebo-controlled trial published in JAMA Dermatology enrolled women with epidermal melasma using daily SPF45 sunscreen, then randomized them to PLE 240 mg twice daily or placebo for 12 weeks. The PLE group showed significantly decreased Melasma Area and Severity Index (MASI) scores (5.7 → 3.3; p<0.05), while the placebo group did not improve [6]. The benefit appears to come from PLE’s ability to dampen the inflammatory and oxidative stress that drives pigment overproduction in melasma — particularly relevant because melasma is notoriously sensitive to even small UV exposures that bypass topical sunscreen.

Safety

The safety profile across multiple studies is strong. The randomized 240 mg twice-daily safety study found no changes in any safety assessments after two months of treatment [3]. Across decades of clinical use in Spain and Latin America, no significant adverse events have been linked to standard doses.

What Polypodium Leucotomos Is Not

A clear understanding of what PLE does makes its limitations obvious:

It is not a replacement for topical sunscreen. The MED increase reported in trials is real but modest — typically equivalent to adding a fraction of an SPF, not multiplying your protection. None of the principal investigators on these studies suggest skipping topical SPF.

It is not the strongest evidence-based anti-aging supplement. The dermatologic evidence base is solid for photoprotection, more limited for general anti-aging, and primarily extrapolated for wrinkle reduction. The strongest topical evidence for reducing visible wrinkles still belongs to retinoids; the strongest preventative evidence still belongs to daily sunscreen for aging skin.

It is not a treatment for an existing sunburn. It works prophylactically — taken regularly before exposure — not as a rescue.

The “oral sunscreen” label oversells it. PLE adds a layer of antioxidant defense to a routine that already includes topical SPF. Anyone using it as a substitute is using it wrong.

Who Actually Benefits

Given the evidence, PLE makes the most sense for:

• People with melasma or persistent hyperpigmentation — particularly the segment for whom topical sunscreen for hyperpigmentation and SPF reapplication still leave residual flaring during sun exposure.
• People with photosensitive conditions — polymorphic light eruption, solar urticaria, and other idiopathic photodermatoses, which is the indication where PLE was originally studied.
• High-UV-exposure professions or activities — outdoor sports, water sports, mountaineering, where reapplication of topical SPF is logistically incomplete.
• People on medications that increase photosensitivity — including some antibiotics, retinoids, and certain antihypertensives. (Always discuss with the prescribing physician.)

It works prophylactically — taken regularly before exposure — not as a rescue.

For someone in a typical office job who already wears daily broad-spectrum SPF, the marginal benefit is real but small. PLE doesn’t replace what already works; it backstops it.

How It’s Typically Used

The dose used in most clinical trials is 240 mg of standardized PLE, taken once or twice daily. For periods of higher sun exposure, two capsules taken approximately 30 minutes before exposure is the most common regimen. The compound has a relatively short half-life, so chronic continuous dosing is not strictly necessary — pre-exposure dosing on high-UV days is the most evidence-aligned approach.

It should be paired with topical sunscreen, not substituted for it.

The Bridge Most People Miss: Antioxidant Defense and Collagen Protection

PLE’s mechanism — neutralizing UV-driven oxidative stress, inhibiting MMPs, sparing collagen — overlaps directly with what topical retinoids and antioxidant serums attempt to do from the outside. The two approaches are complementary rather than competing.

Retinoids upregulate collagen synthesis and downregulate MMP activation in the dermis. Topical antioxidants (vitamin C, ferulic acid, vitamin E) neutralize free radicals at the surface. PLE does similar antioxidant work systemically, reaching tissue layers and times of day that topical products may miss.

The trouble is that conventional topical retinol — even when paired with the best photoprotection regimen — frequently doesn’t reach the dermal fibroblasts where it would actually do the collagen-protective work. Standard retinol formulations rely on solvents and penetration enhancers that destabilize the skin barrier to push the active through, which is why most users experience the redness and peeling that drives them to abandon retinol within weeks.

Nanoretinol takes a different approach to delivery. The retinol is encapsulated in biomimetic lipid nanoparticles — externally identical to skin cells, allowing the epithelial barrier to recognize them as “self” and pass them through intact. The same nanotechnology underpins certain pharmaceutical drug-delivery systems. Comparative testing showed Nanoretinol delivered +232% more collagen recovery and +73% more elastin recovery than conventional retinol, and 56-day clinical use produced a +61% increase in skin firmness and a +56% increase in skin elasticity [7]. The 0.2% concentration looks low until you realize most of conventional retinol’s higher percentages never make it to the dermis.

Pair an evidence-based photoprotection layer (topical SPF + PLE for those who benefit) with a retinoid that actually reaches its target, and you have an internally coherent strategy for the two main drivers of visible aging — UV damage and collagen loss.

A Realistic Verdict

Polypodium leucotomos is one of the rare oral skincare supplements with multiple peer-reviewed randomized controlled trials backing a specific mechanism of action. It is also one of the most commonly oversold. The evidence supports it as an adjunct to topical sunscreen for people whose sun exposure or skin condition justifies an extra layer of antioxidant defense. The evidence does not support it as a replacement for SPF, a stand-alone wrinkle treatment, or a magic capsule that lets you tan safely.

Used correctly — alongside, not instead of, the basics — it is a defensible tool. Used as a substitute, it leaves the skin worse off than the cheaper bottle of broad-spectrum SPF it replaced.

References

1. Gonzalez S, Pathak MA. “Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by polypodium leucotomos.” Photodermatology, Photoimmunology & Photomedicine. 1996;12(2):45-56. doi:10.1111/j.1600-0781.1996.tb00175.x

2. Middelkamp-Hup MA, Pathak MA, Parrado C, et al. “Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin.” Journal of the American Academy of Dermatology. 2004;51(6):910-918. doi:10.1016/j.jaad.2004.06.027

3. Nestor MS, Berman B, Swenson N. “Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects.” Journal of Clinical and Aesthetic Dermatology. 2015;8(2):19-23. PMC4345929

4. Auriemma M, Di Nicola M, Gonzalez S, Piccolo D, Conforti C, Amerio P. “Polypodium leucotomos Supplementation in the Treatment of Scalp Actinic Keratosis: Could It Improve the Efficacy of Photodynamic Therapy?” Dermatologic Surgery. 2015;41(8):898-902. doi:10.1097/DSS.0000000000000425

5. Middelkamp-Hup MA, Pathak MA, Parrado C, et al. “Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin.” Journal of the American Academy of Dermatology. 2004;50(1):41-49. doi:10.1016/S0190-9622(03)02732-4

6. Ahmed AM, Lopez I, Perese F, Vasquez R, Hynan LS, Chong B, Pandya AG. “A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma.” JAMA Dermatology. 2013;149(8):981-983. doi:10.1001/jamadermatol.2013.4294

7. North Biomedical LLC. “Nanoretinol vs. Conventional Retinol: Efficacy in Collagen and Elastin Recovery.” Clinical Study Summary, 2024. https://northbiomedical.com/documents/Nanoretinol-Study_Summary.pdf